Dow Up 0.35% Nasdaq Down 0.02%

Transcept Pharmaceuticals, Inc. (TSPT)

-NasdaqGM
2.20 Aug 20, 3:59PM EDT
Prev Close:2.20
Open:2.16
Bid:2.08 x 1000
Ask:2.34 x 500
1y Target Est:4.20
Beta:0.38
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.16 - 2.27
52wk Range:1.85 - 3.90
Volume:191,836
Avg Vol (3m):217,636
Market Cap:42.15M
P/E (ttm):N/A
EPS (ttm):-1.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TSPT

Comparison

Symbol% ChgMkt Cap
TSPT 0.00%42.15M
APRI71.63M
PTIE184.85M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.50
Ex-Dividend Date:04-Jun-14

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Sep-14) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback